Career disruption emerges as a hidden burden of cancer survivorship, with profound implications for long-term financial security and healthcare access among working adults. While medical advances have dramatically improved cancer survival rates, the economic aftermath reveals a troubling pattern that extends far beyond treatment completion. Japanese health insurance data tracking over 112,000 cancer survivors aged 18-55 revealed that 76.2% experienced job loss within five years of diagnosis—a rate 40% higher than matched controls without cancer. The elevated risk persisted across the entire follow-up period, with men facing 64% higher job loss rates and workers over 50 showing 61% increased risk compared to younger survivors. Certain cancer types proved particularly devastating to employment stability. Brain tumors, pancreatic cancer, skin cancers, and gynecological malignancies carried the highest job loss risk, likely reflecting the intensive treatment regimens and functional impairments associated with these diagnoses. Active chemotherapy and radiation therapy emerged as independent predictors of employment termination. This pattern suggests a cascade effect where cancer treatment's physical demands, cognitive effects, and scheduling requirements create insurmountable workplace challenges. The findings illuminate a critical gap in survivorship care that extends beyond medical monitoring. Unlike acute treatment phases that receive extensive support, the transition back to productive employment appears largely unaddressed in current care models. For the growing population of cancer survivors—now exceeding 18 million Americans—employment preservation strategies may prove as vital as medical interventions for maintaining long-term quality of life and reducing healthcare disparities.